• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The promise and translation of cell-free human papillomavirus DNA testing for cervical cancer surveillance.

作者信息

Garland Justin, Moore Kathleen N, Walker Joan L, Benbrook Doris M

机构信息

Department of Pathology, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Gynecologic Oncology Section, Stephenson Cancer Center, Department of Obstetrics and Gynecology, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

出版信息

Transl Cancer Res. 2025 May 30;14(5):2539-2543. doi: 10.21037/tcr-2025-250. Epub 2025 May 8.

DOI:10.21037/tcr-2025-250
PMID:40530138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12170282/
Abstract
摘要

相似文献

1
The promise and translation of cell-free human papillomavirus DNA testing for cervical cancer surveillance.用于宫颈癌监测的无细胞人乳头瘤病毒DNA检测的前景与转化
Transl Cancer Res. 2025 May 30;14(5):2539-2543. doi: 10.21037/tcr-2025-250. Epub 2025 May 8.
2
Liquid biopsy of HPV DNA in cervical cancer.宫颈癌 HPV DNA 的液体活检。
J Clin Virol. 2019 May;114:32-36. doi: 10.1016/j.jcv.2019.03.005. Epub 2019 Mar 12.
3
Diagnostic utility of cell block preparations from liquid-based cytology in cervical lesions: A comparative retrospective analysis.液基细胞学细胞块制备在宫颈病变中的诊断效用：一项比较性回顾性分析。
Cytojournal. 2025 May 6;22:48. doi: 10.25259/Cytojournal_3_2025. eCollection 2025.
4
Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Patients with Cervical Cancer Undergoing Definitive Chemoradiation.接受根治性放化疗的宫颈癌患者中游离人乳头瘤病毒循环DNA的动力学
Clin Cancer Res. 2025 Feb 17;31(4):697-706. doi: 10.1158/1078-0432.CCR-24-2343.
5
Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis.接种疫苗女性中非疫苗高危型人乳头瘤病毒宫颈感染的患病率：一项系统评价和荟萃分析。
BMC Infect Dis. 2025 Jan 28;25(1):131. doi: 10.1186/s12879-025-10520-6.
6
Trends in HPV-positive cervical cancer prevalence: a retrospective study from 2013 to 2020.人乳头瘤病毒（HPV）阳性宫颈癌患病率趋势：一项2013年至2020年的回顾性研究
Virol J. 2025 Jun 18;22(1):199. doi: 10.1186/s12985-025-02830-7.
7
Microbiome and metabolomic changes associated with HPV clearance in women undergoing local excisional treatment for cervical intraepithelial neoplasia.接受宫颈上皮内瘤变局部切除治疗的女性中与HPV清除相关的微生物组和代谢组变化。
mSystems. 2025 Jun 17;10(6):e0051125. doi: 10.1128/msystems.00511-25. Epub 2025 May 20.
8
Human papillomavirus vaccine uptake and its determinants among women in Africa: an umbrella review.非洲女性人乳头瘤病毒疫苗接种情况及其影响因素：一项综合综述
Front Public Health. 2025 Jun 5;13:1537250. doi: 10.3389/fpubh.2025.1537250. eCollection 2025.
9
Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR.采用数字 PCR 定量分析低体积血清水杨酸样本中的人乳头瘤病毒游离 DNA。
Microbiol Spectr. 2024 Jul 2;12(7):e0002424. doi: 10.1128/spectrum.00024-24. Epub 2024 Jun 3.
10
Prognostic value of circulating HPV cell-free DNA in cervical cancer using liquid biopsy.利用液体活检评估循环人乳头瘤病毒游离DNA在宫颈癌中的预后价值。
Sci Rep. 2025 Apr 3;15(1):11480. doi: 10.1038/s41598-025-93152-9.

本文引用的文献

1
Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Patients with Cervical Cancer Undergoing Definitive Chemoradiation.接受根治性放化疗的宫颈癌患者中游离人乳头瘤病毒循环DNA的动力学
Clin Cancer Res. 2025 Feb 17;31(4):697-706. doi: 10.1158/1078-0432.CCR-24-2343.
2
Prognostic value of human papillomavirus cell-free DNA in cervical cancer patients: A systematic review and meta-analysis.人乳头瘤病毒游离 DNA 在宫颈癌患者中的预后价值：系统评价和荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2024 Sep;300:211-218. doi: 10.1016/j.ejogrb.2024.07.036. Epub 2024 Jul 15.
3
Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer.
游离人乳头瘤病毒DNA是局部晚期宫颈癌预后及复发早期检测的敏感生物标志物。
Clin Cancer Res. 2024 Jul 1;30(13):2764-2771. doi: 10.1158/1078-0432.CCR-23-3941.
4
Immune checkpoint inhibitor therapy in advanced cervical cancer: Deepened response with prolonged treatment and repeat response to re-initiation of therapy.晚期宫颈癌的免疫检查点抑制剂治疗：延长治疗可加深反应，重新开始治疗可再次出现反应。
Gynecol Oncol Rep. 2023 Jul 10;48:101244. doi: 10.1016/j.gore.2023.101244. eCollection 2023 Aug.
5
Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology.用于肿瘤液体分析的Streck游离DNA血液采集管的分析前评估
Diagnostics (Basel). 2023 Mar 29;13(7):1288. doi: 10.3390/diagnostics13071288.
6
Advances in immunotherapy for cervical cancer.宫颈癌免疫治疗的进展
Ther Adv Med Oncol. 2023 Mar 28;15:17588359231163836. doi: 10.1177/17588359231163836. eCollection 2023.
7
Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse.检测宫颈癌患者循环游离 HPV DNA 的 13 种 HPV 类型，作为潜在的生物标志物来监测治疗反应和检测复发。
Br J Cancer. 2023 Jun;128(11):2097-2103. doi: 10.1038/s41416-023-02233-x. Epub 2023 Mar 27.
8
Survival with Cemiplimab in Recurrent Cervical Cancer.西妥昔单抗治疗复发性宫颈癌的生存情况。
N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187.
9
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.派姆单抗治疗持续性、复发性或转移性宫颈癌。
N Engl J Med. 2021 Nov 11;385(20):1856-1867. doi: 10.1056/NEJMoa2112435. Epub 2021 Sep 18.
10
Human papillomavirus E6 and E7: What remains?人乳头瘤病毒 E6 和 E7：还有什么？
Tumour Virus Res. 2021 Jun;11:200213. doi: 10.1016/j.tvr.2021.200213. Epub 2021 Feb 8.